RADU, CLAUDIA-MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.233
EU - Europa 887
AS - Asia 735
SA - Sud America 9
AF - Africa 4
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.873
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.229
CN - Cina 335
SG - Singapore 302
IT - Italia 298
DE - Germania 158
FI - Finlandia 113
SE - Svezia 97
GB - Regno Unito 58
VN - Vietnam 53
FR - Francia 39
RU - Federazione Russa 35
HK - Hong Kong 27
UA - Ucraina 27
NL - Olanda 21
IE - Irlanda 11
IN - India 10
CH - Svizzera 7
AT - Austria 6
BR - Brasile 6
CA - Canada 4
ES - Italia 3
PL - Polonia 3
AU - Australia 2
BE - Belgio 2
CL - Cile 2
DK - Danimarca 2
EU - Europa 2
IR - Iran 2
JP - Giappone 2
LT - Lituania 2
LU - Lussemburgo 2
AR - Argentina 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
IL - Israele 1
KE - Kenya 1
MA - Marocco 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SZ - Regno dello Swaziland 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 7.873
Salva come PNG Salva come JPEG
Città #
Fairfield 1.000
Woodbridge 684
Chandler 540
Ashburn 496
Ann Arbor 466
Houston 393
Seattle 390
Wilmington 340
Cambridge 327
Singapore 210
Santa Clara 154
Boardman 139
Jacksonville 126
Padova 112
San Diego 102
Princeton 98
Beijing 94
Des Moines 68
Medford 68
Helsinki 65
Dong Ket 53
Roxbury 44
Nanjing 30
Milan 29
Hong Kong 27
London 22
Shenyang 17
Falls Church 14
Nanchang 14
New York 14
Guangzhou 13
Jinan 12
Hebei 11
Los Angeles 11
Norwalk 10
Nürnberg 10
Dallas 9
Nuremberg 9
Bologna 8
Changsha 8
Hefei 8
Chicago 7
Dublin 7
Falkenstein 7
Legnaro 7
Munich 7
Tianjin 7
Cagliari 6
Jiaxing 6
Kharkiv 6
Kilburn 6
Ogden 6
Kunming 5
North Bergen 5
Redwood City 5
Taiyuan 5
Washington 5
Amsterdam 4
Basel 4
Ferentino 4
Frankfurt am Main 4
Shanghai 4
Trento 4
Verona 4
Chiswick 3
Detroit 3
Fossò 3
Gunzenhausen 3
Indiana 3
Lappeenranta 3
Martinsicuro 3
Ningbo 3
Rockville 3
Tivoli 3
Vienna 3
Afragola 2
Atlanta 2
Bassano Del Grappa 2
Borås 2
Boston 2
Brentwood 2
Brussels 2
Capriate San Gervasio 2
Cardano al Campo 2
Dearborn 2
Drohobych 2
Haikou 2
Hangzhou 2
Luxembourg 2
Madrid 2
Maserà di Padova 2
Orange 2
Paris 2
Piacenza 2
Podenzana 2
Pordenone 2
Portland 2
Pune 2
Rocca d'Arazzo 2
Rome 2
Totale 6.453
Salva come PNG Salva come JPEG
Nome #
Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles? 202
miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways 198
Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity 185
Peculiar whole blood rotation thromboelastometry (Rotem) profile in 40 sideropenic anaemia patients 176
Dynamics of circulating microparticles in obesity after weight loss 155
Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance 150
Potential role of thrombelastography in the monitoring of acquired factor VIII inhibitor hemophilia A: report on a 78-year-old woman with life-threatening bleedings. 141
Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals 134
X-linked thrombophilia with a mutant factor IX (factor IX Padua). 134
Macrophage-secreted myogenic factors: a promising tool for greatly enhancing the proliferative capacity of myoblasts in vitro and in vivo 132
Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role. 131
Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia 130
Microparticles as biomarkers of venous thromboembolic events 123
Platelet factor V levels in moderate to severe congenital factor V deficiency. 121
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis 121
Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms 120
Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S 120
Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells 118
Whole blood rotation thromboelastometry (ROTEM(®)) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V. 115
Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. 114
Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events 111
Studies on coagulation incompatibilities for xenotransplantation. 110
Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis. 110
Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. 110
New prothrombin mutation (Arg596Trp, Prothrombin Padua 2) associated with venous thromboembolism 108
Effects of long-term administration of recombinant human protein C in xenografted primates. 108
Modulating thrombotic diathesis in hereditary thrombophilia and antiphospholipid antibody syndrome: A role for circulating microparticles? 106
MP062 EXPLORING ALBUMIN UPTAKE IN HUMAN PODOCYTES: A POSSIBLE INVOLVEMENT FOR THE TUBULAR UPTAKE MACHINERY 105
Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women 103
Tailored prophylaxis with rFXIII (NovoThirteen ® ) in a young girl with severe FXIII deficiency and previous cephalohaematoma 103
Similar hypercoagulable state and thrombosis risk in type I and type III proteinS-deficient individuals from mixed type I/III families. 102
Circulating microparticles in pregnant patients with primary anti-phospholipid syndrome: an exploratory study 102
Enhancing myoblast proliferation by using myogenic factors: a promising approach for improving fiber regeneration in sport medicine and skeletal muscle diseases 99
Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis 99
Evaluation of a procoagulant phospholipid functional assay as a routine test for measuring circulating microparticle activity. 98
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct acting antivirals 98
Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis. 93
Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis. 90
Thromboelastographic evaluation of coagulative profiles in pig-to-monkey kidney xenotransplantation. 89
Thrombin activatable fibrinolysis inhibitor in cancer patients with and without venous thromboembolism. 89
The haemostatic system in acromegaly: a single-centre case–control study 89
Similar hypercoagulable state and thrombosis risk in type Iand type III protein S-deficient individuals from families with mixed type I/IIIprotein S deficiency. 87
Reference values for thromboelastometry (ROTEM®) in cynomolgus monkeys (Macaca fascicularis). 87
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma 87
Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis 86
Inherited thrombophilia and venous thromboembolism 85
Association between increased FVIIa-antithrombin complex/FVIIa ratio and pre-eclampsia. 84
The antiproliferative effects of ouabain and everolimus on adrenocortical tumor cells. 84
The aggressive EpCAM+CD45+ phenotype in serous epithelial ovarian cancer 84
Thromboelastometry profiles after “in vitro” addition of a new plasma-derived factor V concentrate to whole blood from parahaemophilia patients 83
Critical review of the evolution of extracellular vesicles’ knowledge: From 1946 to today 83
Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma 81
Circulating microparticles in carriers of prothrombin G20210A mutation. 80
Antisense-based RNA therapy of factor V deficiency: in vitro and ex vivo rescue of a F5 deep-intronic splicing mutation. 79
Circulating glial-derived and tissue factor bearing microparticles in patients with high grade glioma 79
Partial F8 gene duplication (Factor VIII Padua) associated with high factor VIII levels and familial thrombophilia 78
Thrombin generation in patients with COVID-19 with and without thromboprophylaxis 77
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study 75
Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia 74
[Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with rheumatic diseases]. 71
null 71
Microvesicles in bronchoalveolar lavage as a potential biomarker of COPD 70
Albumin uptake in human podocytes: A possible role for the cubilin-amnionless (CUBAM) complex 70
Levels of circulating microparticles in septic shock and sepsis-related complications: A case-control study 66
Immunization with Pentraxin3 prevents transition from subclinical to clinical lupus nephritis in lupus-prone mice: insights from renal ultrastructural findings.   65
Increased Cardiovascular Risk Associated with Chemical Sensitivity to Perfluoro-Octanoic Acid: Role of Impaired Platelet Aggregation 64
Whole blood coagulation assessment using novel rotational thromboelastometry (ROTEM-R) in seen naive cynomologus monkeys 62
Thrombin generation and thromboelastometry in monitoring the in-vitro reversal of warfarin: A comparison between 3-factor and 4-factor prothrombin complex concentrates 61
Thrombin generation profile in cynomolgus monkey recipients of porcine neuronal xenograft 57
PAR-4/Ca2+-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes. 57
Poly(lipoic acid)-based nanoparticles as a new therapeutic tool for delivering active molecules 56
Evaluation of necroptosis related genes RIPK1, RIPK3 and MLKL-p immunogenicity in hepatocellular carcinoma 56
Sounds Stimulation on In Vitro HL1 Cells: A Pilot Study and a Theoretical Physical Model 56
The GIP/GIPR axis in medullary thyroid cancer: clinical and molecular findings 56
Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with rheumatic diseases. 53
Study of the origin of platelets coagulation protein S by human megakaryocyte cultures and characterization of platelets protein S in patients with inherited protein S deficiency 52
Coagulation profile in cynomolgus monkey recipients of porcine neuronal xenograft: a preliminary study 49
Exploring albumin uptake in human podocytes: a possible involvement of the tubular endocytic machinery 47
CHARACTERIZATION OF CIRCULATING MICROPARTICLES DURING NORMAL PREGNANCY 46
Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19 45
Exogenous human α-Synuclein acts in vitro as a mild platelet antiaggregant inhibiting α-thrombin-induced platelet activation 44
Necroptosis-driving genes RIPK1, RIPK3 and MLKL-p are associated with intratumoral CD3+ and CD8+ T cell density and predict prognosis in hepatocellular carcinoma 43
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study 42
null 37
Profiling plasma alterations of extracellular vesicles in patients with acutely decompensated cirrhosis and bacterial infection 30
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 26
Human parietal epithelial cells (PECs) and proteinuria in lupus nephritis: a role for ClC-5, megalin, and cubilin? 23
Increased Soluble Interleukin 6 Receptors in Fabry Disease 21
Macrophages-derived Factor XIII links coagulation to inflammation in COPD 20
Procoagulant phenotype of virus-infected pericytes is associated with portal thrombosis and intrapulmonary vascular dilations in fatal COVID-19 18
Reticulated platelets are increased and hyper-activated in patients with cirrhosis, especially those with poor outcome 17
Additive effect of Bisphenol A and Pefluoro-sulphoctanoic acid exposure at subacute toxic levels, on a murine model of sertoli cell 16
First Evidence of Mineralocorticoid Receptor Gene and Protein Expression in Rat and Human Thyroid Tissues and Cell Cultures 11
Anti-platelet factor 4 antibody-mediated disorders: an updated narrative review 11
Human parietal epithelial cells as Trojan horses in albumin overload 7
Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology 4
Incidence of VTE in asymptomatic children with deficiencies of antithrombin, protein C, and protein S: a prospective cohort study 2
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study 1
Totale 8.018
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.382
article - articoli 31.287
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.669
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020692 0 0 0 0 0 0 0 171 200 174 80 67
2020/20211.368 49 89 107 96 81 55 52 153 152 223 132 179
2021/20221.244 52 73 160 92 95 103 39 170 78 26 101 255
2022/20231.043 175 115 31 143 174 115 6 71 136 11 51 15
2023/2024547 31 78 57 56 39 67 43 43 18 25 40 50
2024/20251.086 5 156 102 93 316 84 152 178 0 0 0 0
Totale 8.018